Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b
Gespeichert in:
| Veröffentlicht in: | The Israel Medical Association journal 2007-06, Vol.9 (6), p.486 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | 486 |
| container_title | The Israel Medical Association journal |
| container_volume | 9 |
| creator | Benjamini, Ohad Kimhi, Oded Lishner, Michael |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_17642403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17642403</sourcerecordid><originalsourceid>FETCH-LOGICAL-p209t-85be284ecdaa9ec549949e88c47066a3f18a5ffc0d5d2af64b4df7566c3c4f3c3</originalsourceid><addsrcrecordid>eNo1j8tKxDAYRrNQnHH0FSQvUEhza7KUwRsMzEJnPfxJ_thILyFthb694mX1cc7iwHdBtrXSqqqZMRtyPU0fjHGlmL0im7rRkksmtuT0ip9YkOYOlzJmLMlDCWlOE4Uh0B8Y-3XMMLcrTUNYPAbqVtqm95aGccJvOWOJWMaBQpdbqLi7IZcRuglv_3ZHTo8Pb_vn6nB8etnfH6rMmZ0roxxyI9EHAIteSWulRWO8bJjWIGJtQMXoWVCBQ9TSyRAbpbUXXkbhxY7c_Xbz4noM51xSD2U9__8TXyOOTVo</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Benjamini, Ohad ; Kimhi, Oded ; Lishner, Michael</creator><creatorcontrib>Benjamini, Ohad ; Kimhi, Oded ; Lishner, Michael</creatorcontrib><identifier>ISSN: 1565-1088</identifier><identifier>PMID: 17642403</identifier><language>eng</language><publisher>Israel</publisher><subject>Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - adverse effects ; Cardiomyopathies - chemically induced ; Cardiomyopathies - etiology ; Humans ; Interferon-alpha - administration & dosage ; Interferon-alpha - adverse effects ; Male ; Melanoma - drug therapy ; Melanoma - surgery ; Middle Aged ; Pericarditis - chemically induced ; Pericarditis - etiology ; Recombinant Proteins ; Risk Factors</subject><ispartof>The Israel Medical Association journal, 2007-06, Vol.9 (6), p.486</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17642403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Benjamini, Ohad</creatorcontrib><creatorcontrib>Kimhi, Oded</creatorcontrib><creatorcontrib>Lishner, Michael</creatorcontrib><title>Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b</title><title>The Israel Medical Association journal</title><addtitle>Isr Med Assoc J</addtitle><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Cardiomyopathies - chemically induced</subject><subject>Cardiomyopathies - etiology</subject><subject>Humans</subject><subject>Interferon-alpha - administration & dosage</subject><subject>Interferon-alpha - adverse effects</subject><subject>Male</subject><subject>Melanoma - drug therapy</subject><subject>Melanoma - surgery</subject><subject>Middle Aged</subject><subject>Pericarditis - chemically induced</subject><subject>Pericarditis - etiology</subject><subject>Recombinant Proteins</subject><subject>Risk Factors</subject><issn>1565-1088</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tKxDAYRrNQnHH0FSQvUEhza7KUwRsMzEJnPfxJ_thILyFthb694mX1cc7iwHdBtrXSqqqZMRtyPU0fjHGlmL0im7rRkksmtuT0ip9YkOYOlzJmLMlDCWlOE4Uh0B8Y-3XMMLcrTUNYPAbqVtqm95aGccJvOWOJWMaBQpdbqLi7IZcRuglv_3ZHTo8Pb_vn6nB8etnfH6rMmZ0roxxyI9EHAIteSWulRWO8bJjWIGJtQMXoWVCBQ9TSyRAbpbUXXkbhxY7c_Xbz4noM51xSD2U9__8TXyOOTVo</recordid><startdate>200706</startdate><enddate>200706</enddate><creator>Benjamini, Ohad</creator><creator>Kimhi, Oded</creator><creator>Lishner, Michael</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200706</creationdate><title>Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b</title><author>Benjamini, Ohad ; Kimhi, Oded ; Lishner, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p209t-85be284ecdaa9ec549949e88c47066a3f18a5ffc0d5d2af64b4df7566c3c4f3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Cardiomyopathies - chemically induced</topic><topic>Cardiomyopathies - etiology</topic><topic>Humans</topic><topic>Interferon-alpha - administration & dosage</topic><topic>Interferon-alpha - adverse effects</topic><topic>Male</topic><topic>Melanoma - drug therapy</topic><topic>Melanoma - surgery</topic><topic>Middle Aged</topic><topic>Pericarditis - chemically induced</topic><topic>Pericarditis - etiology</topic><topic>Recombinant Proteins</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Benjamini, Ohad</creatorcontrib><creatorcontrib>Kimhi, Oded</creatorcontrib><creatorcontrib>Lishner, Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The Israel Medical Association journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benjamini, Ohad</au><au>Kimhi, Oded</au><au>Lishner, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b</atitle><jtitle>The Israel Medical Association journal</jtitle><addtitle>Isr Med Assoc J</addtitle><date>2007-06</date><risdate>2007</risdate><volume>9</volume><issue>6</issue><spage>486</spage><pages>486-</pages><issn>1565-1088</issn><cop>Israel</cop><pmid>17642403</pmid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1565-1088 |
| ispartof | The Israel Medical Association journal, 2007-06, Vol.9 (6), p.486 |
| issn | 1565-1088 |
| language | eng |
| recordid | cdi_pubmed_primary_17642403 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Cardiomyopathies - chemically induced Cardiomyopathies - etiology Humans Interferon-alpha - administration & dosage Interferon-alpha - adverse effects Male Melanoma - drug therapy Melanoma - surgery Middle Aged Pericarditis - chemically induced Pericarditis - etiology Recombinant Proteins Risk Factors |
| title | Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T16%3A43%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20pleuropericarditis%20and%20cardiomyopathy%20induced%20by%20high%20dose%20interferon%20alpha-2b&rft.jtitle=The%20Israel%20Medical%20Association%20journal&rft.au=Benjamini,%20Ohad&rft.date=2007-06&rft.volume=9&rft.issue=6&rft.spage=486&rft.pages=486-&rft.issn=1565-1088&rft_id=info:doi/&rft_dat=%3Cpubmed%3E17642403%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17642403&rfr_iscdi=true |